MetLife, Inc. (NYSE:MET) Shares Sold by OVERSEA CHINESE BANKING Corp Ltd

OVERSEA CHINESE BANKING Corp Ltd trimmed its position in shares of MetLife, Inc. (NYSE:METFree Report) by 69.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,470 shares of the financial services provider’s stock after selling 7,820 shares during the period. OVERSEA CHINESE BANKING Corp Ltd’s holdings in MetLife were worth $284,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. CX Institutional increased its holdings in shares of MetLife by 15.9% during the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock worth $5,568,000 after buying an additional 9,337 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of MetLife by 109.2% during the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock worth $722,727,000 after buying an additional 4,606,748 shares during the last quarter. Smartleaf Asset Management LLC increased its holdings in MetLife by 27.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider’s stock valued at $1,116,000 after purchasing an additional 2,940 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in MetLife by 1.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider’s stock valued at $63,559,000 after purchasing an additional 12,723 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in MetLife in the 3rd quarter valued at $2,960,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Performance

NYSE:MET opened at $82.68 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1-year low of $67.30 and a 1-year high of $89.05. The firm has a 50-day moving average of $83.44 and a two-hundred day moving average of $82.57. The stock has a market cap of $56.33 billion, a P/E ratio of 13.85, a PEG ratio of 0.65 and a beta of 1.04.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were given a dividend of $0.545 per share. The ex-dividend date was Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.64%. MetLife’s payout ratio is 36.52%.

Analyst Ratings Changes

Several analysts recently issued reports on the company. TD Cowen increased their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Morgan Stanley increased their price target on MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a report on Friday, February 28th. BMO Capital Markets assumed coverage on MetLife in a report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target for the company. Keefe, Bruyette & Woods lowered their price target on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a report on Wednesday, February 12th. Finally, Barclays lowered their price target on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $94.58.

Check Out Our Latest Report on MetLife

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.